BLFS
BioLife Solutions, Inc.
NASDAQ · Healthcare · Medical - Instruments & Supplies · US
$35.25
−0.79%Margins
Gross margin
64.5%
EBITDA margin
9.5%
EBIT margin
7.2%
Net margin
49.1%
FCF margin
-0.9%
12.0%
Return on equity
11.3%
Return on assets
1.7%
Return on invested capital
0.24x
Asset turnover
$16.9M
Cash from operations
$1.69
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026